Strategic Maneuvers in Valeant-Allergan Takeover Battle Continue - Presented by: The Aol. On Network

Valeant Pharmaceuticals International has launched its latest strategy in the hostile bidding for Botox maker Allegan Inc. The target of the $54 billion, unsolicited takeover attempt has repeatedly attempted to thwart the suitor's buyout advances, only to see Valeant come at it with another maneuver.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.71 0.09 ▲ 0.51%
GILD $ 92.90 15.55 ▼ 14.34%
RAD $ 7.15 0.38 ▲ 5.61%
AAPL $ 112.94 1.16 ▲ 1.04%
PBR $ 7.45 0.34 ▲ 4.78%
ACHN $ 15.49 1.28 ▲ 9.01%
GE $ 25.71 0.09 ▲ 0.35%
QQQ $ 104.58 0.26 ▲ 0.25%

As of 12/22/2014, 04:15 PM
More Most Active